LTRNProduct Launch•businesswire•
Lantern Pharma Announces Public Release of Transformative, Advanced AI Module for Blood-Brain Barrier Permeability Prediction, predictBBB.ai™
Sentiment:Positive (85)
Summary
DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc. (NASDAQ: LTRN), a pioneering artificial intelligence company transforming oncology drug discovery and development, today announced the public release of its AI module for predicting blood-brain barrier (BBB) permeability of small molecules with unprecedented accuracy and scalability – predictBBB.ai™. This critical advancement addresses one of pharmaceutical development's most persistent challenges—that only 2-6% of small-molecule drugs can successful
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 4, 2025 by businesswire